Our Dedication to the
Communities We Serve
ALS & Parkinson’s disease are beginning to get the level of attention they deserve. We’re building on this much-needed momentum and focus, joining forces with the communities we serve to make a better tomorrow a reality.
People living with devastating diseases (and their families) deserve a platform, support system and access to the information they need to make informed decisions. Whether we’re working with like-minded organizations or sharing powerful stories of resilience—one thing is certain: MTPA shows up for the community.
The JourneyMate Support Program™
A Focused Approach to Treatment Support
No matter where someone is at in their ALS journey—from diagnosis to treatment—the JourneyMate Support Program™ gives them the understanding, answers and resources to help them move forward. Experienced program team members are trained to address their educational needs and provide them with personalized answers and resources for living with challenging diseases. This program is here to supplement the resources that their doctor provides.
The JourneyMate Support Program™ offers educational support and resources for patients who are considering or have already been prescribed a Mitsubishi Tanabe Pharma America, Inc. (MTPA) product. A Clinical Educator is an educational resource for patients who have been prescribed an MTPA product. A Clinical Educator is provided by MTPA and VMS and is not affiliated with or provided by a doctor. A Clinical Educator does not provide medical advice. The program does not provide medical advice and does not take the place of a patient’s doctor. All questions about a condition, diagnosis, or treatment should be referred to the patient’s doctor. If a patient has a medical emergency, they should call 911. Adverse events or product complaints should be reported by calling 1-888-292-0058.
The Share Your Story program was designed by MTPA to help people living with rare, progressive, neurological conditions and their caregivers share experiences of diagnosis and treatment. People can participate in the program by making a video, writing an article or creating social content. When they share their experiences, it may help others on the same journey feel like they’re part of a larger group of support and understanding.
If you’re interested in enrolling in an MTPA clinical trial or simply want to obtain more information, follow the link below.
Learn MoreORGANIZATIONS
Organizations Who Share Our Commitment
Giving a voice to people with ALS and PD (and those who care for them) is integral to the work we do. That’s why we partner with a variety of organizations that share our goal of improving patient lives.
Registration of Clinical Trial Information and Disclosure of Results
a. Registration of our clinical trial information, and disclosure of results, to clinical trial registries
MTPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.
b. Disclosure of clinical trial summary results
MTPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if MTPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions:
- A third party, such as a company involved in joint development, has not agreed to disclosure.
- Disclosure may interfere with publication in medical journals.
- Disclosure may interfere with the protection of intellectual property rights.